Shelton Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Sell |
69,091
-9
| -0% | -$629 | 0.11% | 162 |
|
|
2025
Q1 | $5.08M | Sell |
69,100
-3,081
| -4% | -$226K | 0.12% | 152 |
|
|
2024
Q4 | $4.73M | Buy |
72,181
+1,420
| +2% | +$93K | 0.12% | 161 |
|
|
2024
Q3 | $5.51M | Hold |
70,761
| – | – | 0.14% | 141 |
|
|
2024
Q2 | $5.52M | Hold |
70,761
| – | – | 0.15% | 137 |
|
|
2024
Q1 | $4.79M | Buy |
70,761
+1,095
| +2% | +$74.2K | 0.14% | 164 |
|
|
2023
Q4 | $4.69M | Buy |
69,666
+4,352
| +7% | +$293K | 0.15% | 158 |
|
|
2023
Q3 | $4.42M | Buy |
65,314
+14,286
| +28% | +$967K | 0.16% | 153 |
|
|
2023
Q2 | $3.65M | Buy |
51,028
+1,956
| +4% | +$140K | 0.13% | 164 |
|
|
2023
Q1 | $3.41M | Sell |
49,072
-535
| -1% | -$37.1K | 0.14% | 156 |
|
|
2022
Q4 | $3.36M | Sell |
49,607
-1,420
| -3% | -$96.3K | 0.35% | 89 |
|
|
2022
Q3 | $2.8M | Hold |
51,027
| – | – | 0.13% | 165 |
|
|
2022
Q2 | $3.37M | Hold |
51,027
| – | – | 0.15% | 152 |
|
|
2022
Q1 | $3.39M | Buy |
+51,027
| New | +$3.39M | 0.13% | 171 |
|
|
2016
Q2 | – | Sell |
-10,200
| Closed | -$287K | – | 753 |
|
|
2016
Q1 | $287K | Hold |
10,200
| – | – | 0.03% | 572 |
|
|
2015
Q4 | $346K | Hold |
10,200
| – | – | 0.03% | 472 |
|
|
2015
Q3 | $325K | Hold |
10,200
| – | – | 0.04% | 495 |
|
|
2015
Q2 | $325K | Hold |
10,200
| – | – | 0.03% | 541 |
|
|
2015
Q1 | $349K | Sell |
10,200
-600
| -6% | -$20.5K | 0.04% | 521 |
|
|
2014
Q4 | $380K | Sell |
10,800
-400
| -4% | -$14.1K | 0.04% | 486 |
|
|
2014
Q3 | $400K | Buy |
+11,200
| New | +$400K | 0.05% | 424 |
|